GRAMD4
GRAM domain-containing protein 4
Also known as: DIP, GRAM4_HUMAN, KIAA0767
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6IC98
- Gene
- GRAMD4
- Ensembl
- ENSG00000075240
- Chromosome
- 22
- Canonical length
- 578 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
GRAMD4 is a mitochondrial effector of E2F1 (MIM 189971)-induced apoptosis (Stanelle et al., 2005 [PubMed 15565177]).[supplied by OMIM, Jan 2011]
Canonical amino-acid sequenceUniProt
578 residues, UniProt reviewed canonical sequence.
>Q6IC98|GRAMD4
1 MLRRLDKIRF RGHKRDDFLD LAESPNASDT ECSDEIPLKV PRTSPRDSEE LRDPAGPGTL
61 IMATGVQDFN RTEFDRLNEI KGHLEIALLE KHFLQEELRK LREETNAEML RQELDRERQR
121 RMELEQKVQE VLKARTEEQM AQQPPKGQAQ ASNGAERRSQ GLSSRLQKWF YERFGEYVED
181 FRFQPEENTV ETEEPLSARR LTENMRRLKR GAKPVTNFVK NLSALSDWYS VYTSAIAFTV
241 YMNAVWHGWA IPLFLFLAIL RLSLNYLIAR GWRIQWSIVP EVSEPVEPPK EDLTVSEKFQ
301 LVLDVAQKAQ NLFGKMADIL EKIKNLFMWV QPEITQKLYV ALWAAFLASC FFPYRLVGLA
361 VGLYAGIKFF LIDFIFKRCP RLRAKYDTPY IIWRSLPTDP QLKERSSAAV SRRLQTTSSR
421 SYVPSAPAGL GKEEDAGRFH STKKGNFHEI FNLTENERPL AVCENGWRCC LINRDRKMPT
481 DYIRNGVLYV TENYLCFESS KSGSSKRNKV IKLVDITDIQ KYKVLSVLPG SGMGIAVSTP
541 STQKPLVFGA MVHRDEAFET ILSQYIKITS AAASGGDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRAMD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 167 nTPM
Expression across tissuesHPA
Tissue
- liver: 167 nTPM
- adrenal gland: 55 nTPM
- skin: 43 nTPM
- heart muscle: 40 nTPM
- colon: 38 nTPM
- small intestine: 34 nTPM
Single-cell type
- thymocytes: 132 nCPM
- pancreatic islet cells: 127 nCPM
- megakaryocyte-erythroid progenitors: 121 nCPM
- enterocytes: 120 nCPM
- retinal pigment epithelial cells: 81 nCPM
- colonocytes: 76 nCPM
Immune cell
- NK-cell: 3.9 nTPM
- plasmacytoid DC: 2.4 nTPM
- myeloid DC: 2 nTPM
- T-reg: 1.9 nTPM
- classical monocyte: 1.4 nTPM
- basophil: 1.2 nTPM
Brain region
- cerebral cortex: 62 nTPM
- basal ganglia: 54 nTPM
- hippocampal formation: 53 nTPM
- amygdala: 52 nTPM
- white matter: 50 nTPM
- pons: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.56
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- negative regulation of toll-like receptor 9 signaling pathway
- positive regulation of apoptotic process
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GRAM domain
- PH-like domain superfamily
- GRAM domain
- GRAMDC4, PH-GRAM domain
- GRAM domain-containing protein 4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRAMD4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRAMD4 as an antibody target. Whether an autoantibody or antibody against GRAMD4 could matter depends on whether native GRAMD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRAMD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRAMD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...